Quantcast

Latest OSI Pharmaceuticals Stories

2006-06-30 19:20:42

By Lisa Richwine WASHINGTON (Reuters) - A Genentech Inc. drug that reversed vision loss in some patients won U.S. approval on Friday for treating the leading cause of blindness in the elderly. Injected into the eye monthly, the drug Lucentis maintained vision in 95 percent of patients with the wet form of age-related macular degeneration (AMD) who were treated for 12 months. Eyesight improved in one-third of patients, the Food and Drug Administration said. "The 95 percent retention...

2006-04-07 16:10:48

WASHINGTON (Reuters) - Pfizer Inc. and OSI Pharmaceuticals Inc. have reported rare cases of serious allergic reactions with use of their eye drug Macugen along with other medications, the U.S. Food and Drug Administration said on Friday. The companies earlier this month notified doctors about the reactions, which included allergic swelling around the eyes or lips and other anaphylactic symptoms, the FDA said. Information about the reports has been added to the drug's label, the...

2005-10-19 07:19:29

CHICAGO (Reuters) - Genentech Inc. said on Tuesday early results from a mid-stage trial show that combining lung cancer drug Tarceva with Avastin works no better than Avastin alone in patients with advanced kidney cancer, sending shares of Tarceva partner OSI Pharmaceuticals Inc. down 7 percent. As a result, the world's No. 2 biotechnology company said it will not pursue further studies of the Avastin/Tarceva combination in kidney cancer but will continue to analyze the results of...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related